Product Description: DCDQ is a potent acetylcholinesterase (AChE) inhibitor. DCDQ shows a strong binding affinity with the 4EY7 protein (binding energy: −8.2 kcal/mol). DCDQ is promising for research of Alzheimer's disease (AD)[1].
Formula: C10H8Cl2N2O2
References: [1]Asokan K, et al. Spectroscopic, DFT, In Silico, and Estimation of Biological Activity of 2, 4‐Dichloro‐6, 7‐Dimethoxyquinazoline as a Potential Anti‐Alzheimer's Disease Therapeutic Agent[J]. International Journal of Quantum Chemistry, 2025, 125(1): e70006.
CAS Number: 27631-29-4
Molecular Weight: 259.09
Research Area: Neurological Disease
Target: Cholinesterase (ChE)